Lactic acidosis

New England Journal of Medicine

Volumn 371, Issue 24, 2014, Pages 2309-2319

  Kraut, Jeffrey A ^a,b,c   Madias, Nicolaos E ^d,e  

^a Membrane Biology Laboratory   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^d ST ELIZABETH'S MEDICAL CENTER   (United States)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALCOHOL; ANTIRETROVIRUS AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CATECHOLAMINE DERIVATIVE; COCAINE; CYANIDE; DIETHYLENE GLYCOL; ETHYLENE GLYCOL; HEMOGLOBIN; LACTATE DEHYDROGENASE; LACTIC ACID; METFORMIN; METHANOL; PROPOFOL; PROPYLENE GLYCOL; PROTEIN INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SALICYLIC ACID DERIVATIVE; SODIUM PROTON EXCHANGE PROTEIN 1 INHIBITOR; UNCLASSIFIED DRUG; BICARBONATE;

AIR CONDITIONING; ANAEROBIC GLYCOLYSIS; ANEMIA; ANION GAP; ARTERIAL GAS; ARTERIAL OXYGEN SATURATION; CARBON MONOXIDE INTOXICATION; CARDIOGENIC SHOCK; CARDIOVASCULAR DISEASE; CELL FUNCTION; CENTRAL VENOUS OXYGEN SATURATION; CHRONIC LIVER DISEASE; CIRCULATION; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENCY; EXERCISE; HEART FAILURE; HEART MUSCLE PERFUSION; HUMAN; HYPERLACTATEMIA; HYPOTENSION; HYPOVOLEMIC SHOCK; HYPOXEMIA; INJURY; KETOACIDOSIS; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LIVER DISEASE; LUNG DISEASE; LUNG GAS EXCHANGE; LUNG WEDGE PRESSURE; MALIGNANT NEOPLASTIC DISEASE; MICROCIRCULATION; MICROVASCULATURE; MORBIDITY; NEAR INFRARED SPECTROSCOPY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN SATURATION; OXYGEN THERAPY; PATHOGENESIS; PATIENT MONITORING; PHEOCHROMOCYTOMA; PROGNOSIS; RESUSCITATION; REVIEW; RISK FACTOR; SEIZURE; SENSITIVITY AND SPECIFICITY; SEPSIS; SHIVERING; THIAMINE DEFICIENCY; URINE VOLUME; VIGOROUS EXERCISE; ACID BASE BALANCE; ACIDOSIS, LACTIC; FLUID THERAPY; METABOLISM;

ACID-BASE EQUILIBRIUM; ACIDOSIS, LACTIC; FLUID THERAPY; HUMANS; HYPERLACTATEMIA; LACTIC ACID; PROGNOSIS; SODIUM BICARBONATE;

EID: 84918545715     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1309483     Document Type: Review

References (61)

1. Gunnerson KJ, Saul M, He S, Kellum JA. Lactate versus non-lactate metabolic acidosis: A retrospective outcome evaluation of critically ill patients. Crit Care 2006; 10: R22-R32.
2. Nichol AD, Egi M, Pettila V, et al. Relative hyperlactatemia and hospital mortality in critically ill patients: A retrospective multi-centre study. Crit Care 2010; 14: R25.
3. Doherty JR, Cleveland JL. Targeting lactate metabolism for cancer therapeutics. J Clin Invest 2013; 123: 3685-92.
4. Madias NE. Lactic acidosis. Kidney Int 1986; 29: 752-74.
5. van Hall G. Lactate kinetics in human tissues at rest and during exercise. Acta Physiol (Oxf) 2010; 199: 499-508.
6. Kruse O, Grunnet N, Barfod C. Blood lactate as a predictor for in-hospital mortality in patients admitted acutely to hospital: A systematic review. Scand J Trauma Resusc Emerg Med 2011; 19: 74.
7. Bakker J, Nijsten MW, Jansen TC. Clinical use of lactate monitoring in critically ill patients. Ann Intensive Care 2013; 3: 12.
8. Ince C. The microcirculation is the motor of sepsis. Crit Care 2005; 9: Suppl 4: S13-S19.
9. Levy B, Desebbe O, Montemont C, Gibot S. Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states. Shock 2008; 30: 417-21.
10. Taylor DJ, Faragher EB, Evanson JM. Inflammatory cytokines stimulate glucose uptake and glycolysis but reduce glucose oxidation in human dermal fibroblasts in vitro. Circ Shock 1992; 37: 105-10.
11. Jeppesen JB, Mortensen C, Bendtsen F, Møller S. Lactate metabolism in chronic liver disease. Scand J Clin Lab Invest 2013 March 20 (Epub ahead of print).
12. Levraut J, Ciebiera JP, Chave S, et al. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 1998; 157: 1021-6.
13. Murphy ND, Kodakat SK, Wendon JA, et al. Liver and intestinal lactate metabolism in patients with acute hepatic failure undergoing liver transplantation. Crit Care Med 2001; 29: 2111-8.
14. Kraut JA, Madias NE. Treatment of acute metabolic acidosis: A pathophysiologic approach. Nat Rev Nephrol 2012; 8: 589-601.
15. Lee SW, Hong YS, Park DW, et al. Lactic acidosis not hyperlactatemia as a predictor of in hospital mortality in septic emergency patients. Emerg Med J 2008; 25: 659-65.
16. Mustafa I, Leverve XM. Metabolic and hemodynamic effects of hypertonic solutions: Sodium-lactate versus sodium chloride infusion in postoperative patients. Shock 2002; 18: 306-10.
17. Jung B, Rimmele T, Le Goff C, et al. Severe metabolic or mixed acidemia on intensive care unit admission: Incidence, prognosis and administration of buffer therapy: A prospective, multiple-center study. Crit Care 2011; 15: R238.
18. Iberti TJ, Leibowitz AB, Papadakos PJ, Fischer EP. Low sensitivity of the anion gap as a screen to detect hyperlactatemia in critically ill patients. Crit Care Med 1990; 18: 275-7.
19. Kraut JA, Madias NE. Serum anion gap: Its uses and limitations in clinical medicine. Clin J Am Soc Nephrol 2007; 2: 162-74.
20. Madias NE, Homer SM, Johns CA, Cohen JJ. Hypochloremia as a consequence of anion gap metabolic acidosis. J Lab Clin Med 1984; 104: 15-23.
21. Khosravani H, Shahpori R, Stelfox HT, Kirkpatrick AW, Laupland KB. Occurrence and adverse effect on outcome of hyperlactatemia in the critically ill. Crit Care 2009; 13: R90.
22. del Portal DA, Shofer F, Mikkelsen ME, et al. Emergency department lactate is associated with mortality in older adults admitted with and without infections. Acad Emerg Med 2010; 17: 260-8.
23. Bakker J, Jansen TC. Don't take vitals, take a lactate. Intensive Care Med 2007; 33: 1863-5.
24. Fall PJ, Szerlip HM. Lactic acidosis: From sour milk to septic shock. J Intensive Care Med 2005; 20: 255-71.
25. Schelling JR, Howard RL, Winter SD, Linas SL. Increased osmolal gap in alcoholic ketoacidosis and lactic acidosis. Ann Intern Med 1990; 113: 580-2.
26. Vincent JL, De Backer D. Circulatory shock. N Engl J Med 2013; 369: 1726-34.
27. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368-77.
28. Severs D, Hoorn EJ, Rookmaaker MB. A critical appraisal of intravenous fluids: From the physiological basis to clinical evidence. Nephrol Dial Transplant 2014 January 23 (Epub ahead of print).
29. O'Dell E, Tibby SM, Durward A, Murdoch IA. Hyperchloremia is the dominant cause of metabolic acidosis in the postresuscitation phase of pediatric meningococcal sepsis. Crit Care Med 2007; 35: 2390-4.
30. Cooper DJ, Walley KR, Wiggs BR, Russell JA. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: A prospective, controlled clinical study. Ann Intern Med 1990; 112: 492-8.
31. Gennari FJ. Intravenous fluid therapy: Saline versus mixed electrolyte and organic anion solutions. Am J Kidney Dis 2013; 62: 20-2.
32. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloriderestrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308: 1566-72.
33. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013; 369: 1243-51.
34. Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma- Lyte. Ann Surg 2012; 255: 821-9.
35. Kuze S, Naruse T, Yamazaki M, Hirota K, Ito Y, Miyahara T. Effects of sodium L-lactate and sodium racemic lactate on intraoperative acid-base status. Anesth Analg 1992; 75: 702-7.
36. Didwania A, Miller J, Kassel D, Jackson EV Jr, Chernow B. Effect of intravenous lactated Ringer's solution infusion on the circulating lactate concentration: Part 3. Results of a prospective, randomized, double-blind, placebo-controlled trial. Crit Care Med 1997; 25: 1851-4.
37. Sakr Y, Dubois MJ, De Backer D, Creteur J, Vincent JL. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004; 32: 1825-31.
38. De Backer D, Creteur J, Dubois MJ, et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006; 34: 403-8.
39. De Backer D, Donadello K, Sakr Y, et al. Microcirculatory alterations in patients with severe sepsis: Impact of time of assessment and relationship with outcome. Crit Care Med 2013; 41: 791-9.
40. Adrogué HJ, Madias NE. Management of life-threatening acid-base disorders: First of two parts. N Engl J Med 1998; 338: 26-34.
41. Kraut JA, Kurtz I. Use of base in the treatment of severe acidemic states. Am J Kidney Dis 2001; 38: 703-27.
42. Kim HJ, Son YK, An WS. Effect of sodium bicarbonate administration on mortality in patients with lactic acidosis: A retrospective analysis. PLoS One 2013; 8(6): E65283.
43. Hood VL, Tannen RL. Protection of acid-base balance by pH regulation of acid production. N Engl J Med 1998; 339: 819-26.
44. Wu DM, Qi JS, Dai H, Doods H, Abraham WM. Resuscitation with Na+/H+ exchanger inhibitor in traumatic haemorrhagic shock: Cardiopulmonary performance, oxygen transport and tissue inflammation. Clin Exp Pharmacol Physiol 2010; 37: 337-42.
45. Wu DM, Kraut JA, Abraham WM. Sabiporide improves cardiovascular function, decreases the inflammatory response and reduces mortality in acute metabolic acidosis in pigs. PLoS One 2013; 8(1): E53932.
46. Swietach P, Vaughan-Jones RD, Harris AL, Hulikova A. The chemistry, physiology and pathology of pH in cancer. Philos Trans R Soc Lond B Biol Sci 2014; 369: 20130099.
47. Okorie ON, Dellinger P. Lactate: Biomarker and potential therapeutic target. Crit Care Clin 2011; 27: 299-326.
48. Yealy DM, Kellum JA, Huang DT, et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370: 1683-93.
49. Jansen TC, van Bommel J, Schoonderbeek FJ, et al. Early lactate-guided therapy in intensive care unit patients: A multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med 2010; 182: 752-61.
50. Jones AE. Point: Should lactate clearance be substituted for central venous oxygen saturation as goals of early severe sepsis and septic shock therapy? Yes. Chest 2011; 140: 1406-8.
51. Fuller BM, Dellinger RP. Lactate as a hemodynamic marker in the critically ill. Curr Opin Crit Care 2012; 18: 267-72.
52. James JH, Luchette FA, McCarter FD, Fischer JE. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999; 354: 505-8.
53. Textoris J, Beaufils N, Quintana G, et al. Hypoxia-inducible factor (HIF1a) gene expression in human shock states. Crit Care 2012; 16: R120.
54. van Beest PA, Brander L, Jansen SP, Rommes JH, Kuiper MA, Spronk PE. Cumulative lactate and hospital mortality in ICU patients. Ann Intensive Care 2013; 3: 6.
55. Vanni S, Viviani G, Baioni M, et al. Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: The thrombo-embolism lactate outcome study. Ann Emerg Med 2013; 61: 330-8.
56. Andersen LW, Mackenhauer J, Roberts JC, Berg KM, Cocchi MN, Donnino MW. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc 2013; 88: 1127-40.
57. Kliegel A, Losert H, Sterz F, et al. Serial lactate determinations for prediction of outcome after cardiac arrest. Medicine (Baltimore) 2004; 83: 274-9.
58. Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: A randomized clinical trial. JAMA 2010; 303: 739-46.
59. Murtuza B, Wall D, Reinhardt Z, et al. The importance of blood lactate clearance as a predictor of early mortality following the modified Norwood procedure. Eur J Cardiothorac Surg 2011; 40: 1207-14.
60. Sakr Y. Techniques to assess tissue oxygenation in the clinical setting. Transfus Apher Sci 2010; 43: 79-94.
61. Adrogué HJ, Rashad MN, Gorin AB, Yacoub J, Madias NE. Assessing acid-base status in circulatory failure: Differences between arterial and central venous blood. N Engl J Med 1989; 320: 1312-6.